Avalyn Pharma Funding: $211M Raised, Series B (2020)
Avalyn Pharma is a Biotech company based in Seattle. It has raised $211M in total funding. Latest round: Series B.
Avalyn Pharma funding overview
Avalyn Pharma is a Biotech company based in Seattle. Avalyn Pharma has raised $211M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2020. The round record for Avalyn Pharma runs through 2020; nothing later has been disclosed. Investors on record include SR One Capital Management, Catalio Capital Management, Piper Heartland, Norwest Venture Partners, Pivotal bioVenture Partners, F-Prime Capital and 4 others. 10 distinct backers are named across the disclosed rounds.
Avalyn Pharma at a glance
Total raised
$211M
Latest round
Series B
Latest round date
January 2020
Industry
Biotech
Headquarters
Seattle
Notable investors
SR One Capital Management, Catalio Capital Management, Piper Heartland, Norwest Venture Partners, Pivotal bioVenture Partners, F-Prime Capital, Novo Holdings, TPG Biotech
Frequently asked about Avalyn Pharma funding
How much has Avalyn Pharma raised?
Avalyn Pharma has raised $211M in total disclosed funding across the rounds on record.
Who has invested in Avalyn Pharma?
SR One Capital Management, Catalio Capital Management, Piper Heartland, Norwest Venture Partners, Pivotal bioVenture Partners, F-Prime Capital are named among the investors backing Avalyn Pharma.
What was the latest Avalyn Pharma funding round?
The most recent disclosed round is a Series B, announced in January 2020.
Where is Avalyn Pharma based?
Avalyn Pharma is based in Seattle.
What sector does Avalyn Pharma operate in?
Avalyn Pharma is tracked under Biotech from Seattle, with $211M in disclosed funding.
When did Avalyn Pharma last raise?
The last disclosed Avalyn Pharma round closed in January 2020 at Series B.
Round data for Avalyn Pharma is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Seattle and backer lists below.
